Back

Temporal trends in stroke prevalence and its associations with changing patterns of antithrombotic regimens in patients with atrial fibrillation and a wide spectrum of coronary artery disease

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Epidemiology of atrial fibrillation Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Bartosz Hudzik

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

32 More presentations in this session

Presentation thumbnail
Left atrial enlargement as an independent risk factor for ischemic stroke in Japanese atrial fibrillation patients: pooled analysis of five major Japanese atrial fibrillation registries
Doctor M. Akao (Kyoto, JP)
Abstract Slides
Presentation thumbnail
Diverse activation patterns during persistent atrial fibrillation characterised by dipole density non-contact mapping
Doctor R. Shi (London, GB)
Abstract Slides
Presentation thumbnail
Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?
Assistant Professor V. Ionin (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Clinical characteristics and outcomes of atrial fibrillation patients with thrombocytopenia: the Fushimi AF Registry
Doctor K. Ishigami (Kyoto, JP)
Abstract
Presentation thumbnail
Comparison of equations for renal function assessment and major adverse outcomes in atrial fibrillation: an analysis from the EORP-AF long-term general registry
Professor G. Boriani (Modena, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Epidemiology of atrial fibrillation

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - pro
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources